Phase 4 Epilepsy Clinical Trials
13 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–13 of 13 trials
Recruiting
Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
Epilepsy
VA Office of Research and Development226 enrolled4 locationsNCT04419272
Recruiting
Phase 4
Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care
Epilepsy
University Hospitals Cleveland Medical Center30 enrolled2 locationsNCT06346262
Recruiting
Phase 4
Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy
Cognitive ImpairmentFocal Epilepsy
First Affiliated Hospital of Wenzhou Medical University220 enrolled1 locationNCT07193277
Recruiting
Phase 4
Pharmacogenetics-Based Study on Individualized Use of Sodium Valproate
Epilepsy
The First Affiliated Hospital of University of South China312 enrolled1 locationNCT07046676
Recruiting
Phase 4
A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
Epilepsy, Tonic-ClonicEpilepsies, Partial
Affiliated Hospital of Nantong University30 enrolled1 locationNCT06967012
Not Yet Recruiting
Phase 4
Profiling how female sex steroids affect the brain perimenstrually
Catamenial epilepsy
The University of Auckland150 enrolled1 locationACTRN12624000803594
Recruiting
Phase 4
Effect of GABA on ADHD and Seizures in Children With Epilepsy.
Epilepsy
Sherief Abd-Elsalam30 enrolled1 locationNCT04144439
Terminated
Phase 4
EpiNet-First Trial 1: Comparison of efficacy of levetiracetam, lamotrigine and carbamazepine in people with previously untreated epilepsy who have focal seizures.
Epilepsy
EpiNet Study Group1,467 enrolled8 locationsACTRN12615000643572
Terminated
Phase 4
EpiNet-First Trial 5: Comparison of efficacy of levetiracetam and lamotrigine in people with previously untreated epilepsy who have unclassified seizures, and for whom sodium valporate is not deemed an acceptable anti-epileptic drug.
Epilepsy
EpiNet Study Group664 enrolled8 locationsACTRN12615000641594
Terminated
Phase 4
EpiNet-First Trial 4: Comparison of efficacy of levetiracetam, lamotrigine and sodium valproate in people with previously untreated epilepsy who have unclassified seizures.
Epilepsy
EpiNet Study Group1,176 enrolled8 locationsACTRN12615000640505
Terminated
Phase 4
EpiNet-First Trial 3: Comparison of efficacy of levetiracetam and lamotrigine in people with previously untreated epilepsy who have generalised seizures, and for whom sodium valporate is not deemed an acceptable anti-epileptic drug.
Epilepsy
EpiNet Study Group664 enrolled8 locationsACTRN12615000639527
Terminated
Phase 4
EpiNet-First Trial 2: Comparison of efficacy of levetiracetam and sodium valproate in people with previously untreated epilepsy who have generalised seizures.
Epilepsy
EpiNEt Study Group506 enrolled8 locationsACTRN12615000556549
Recruiting
Phase 4
Neuropsychiatric, Neurocognitive And Quality Of Life Outcomes In Patients With Epilepsy Treated With Levetiracetam (Keppra) Verses Older AEDs As First Substitution Monotherapy.
Epilepsy
Associate Prof. Terence O'Brien and RMH Neurosciences Foundation200 enrolled1 locationACTRN12606000102572